Fed­er­al judge toss­es out an­titrust law­suit against Eli Lil­ly, Sanofi over di­a­betes drug dis­counts

A fed­er­al judge in New York dis­missed an an­titrust law­suit against drug­mak­ers al­leg­ing that they con­spired to boost prof­its by lim­it­ing dis­counts on in­sulin be­gin­ning in 2020.

Mo­sa­ic Health and Cen­tral Vir­ginia Health Ser­vices, both non­prof­it health­care providers, filed the law­suit in 2021 in the US Dis­trict Court for the West­ern Dis­trict of New York. They al­leged that Sanofi, Eli Lil­ly, No­vo Nordisk and As­traZeneca broke state and fed­er­al laws by “sud­den­ly, and in co­or­di­na­tion with one an­oth­er,” agree­ing to lim­it drug dis­counts through the fed­er­al 340B pro­gram, which al­lows safe­ty-net hos­pi­tals and clin­ics to buy drugs like in­sulin at cheap­er prices.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER